Shine Investment Advisory Services’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$119K Sell
1,487
-313
-17% -$24.4K 0.04% 174
2020
Q2
$124K Hold
1,800
0.05% 165
2020
Q1
$113K Sell
1,800
-138
-7% -$9.95K 0.05% 164
2019
Q4
$151K Sell
1,938
-120
-6% -$9.37K 0.06% 152
2019
Q3
$151K Sell
2,058
-36
-2% -$2.53K 0.07% 131
2019
Q2
$129K Sell
2,094
-150
-7% -$9.07K 0.06% 144
2019
Q1
$143K Sell
2,244
-540
-19% -$30.8K 0.07% 138
2018
Q4
$142K Sell
2,784
-609
-18% -$30.8K 0.07% 132
2018
Q3
$197K Sell
3,393
-459
-12% -$22.4K 0.1% 109
2018
Q2
$187K Sell
3,852
-69
-2% -$3.22K 0.1% 112
2018
Q1
$182K Hold
3,921
0.1% 104
2017
Q4
$147K Buy
3,921
+579
+17% +$21.2K 0.07% 114
2017
Q3
$122K Buy
3,342
+138
+4% +$5.26K 0.06% 137
2017
Q2
$126K Buy
+3,204
New +$117K 0.06% 127

Other funds holding EW

Shine Investment Advisory Services's EW Position: Q3 2020 in Review

Shine Investment Advisory Services reduced its Edwards Lifesciences (EW) stake by 17% in Q3 2020, selling an estimated $24.4K and leaving 1,487 shares worth $119K. The position accounts for 0.04% of the portfolio, ranked #174.

Shine Investment Advisory Services first reported a position in EW in Q2 2017 and has held it in 14 quarters since. The position peaked at $197K in Q3 2018. 1,084 funds tracked by Wall St. Rank hold EW as of Q3 2020.

  • Shine Investment Advisory Services held 1,487 shares of Edwards Lifesciences worth $119K as of Q3 2020.
  • Shine Investment Advisory Services sold 313 Edwards Lifesciences shares in Q3 2020, an estimated $24.4K.
  • Edwards Lifesciences made up 0.04% of Shine Investment Advisory Services's portfolio in Q3 2020, its #174 holding.
  • Shine Investment Advisory Services first reported a position in Edwards Lifesciences in Q2 2017 and has held it in 14 quarters since.
  • Shine Investment Advisory Services's Edwards Lifesciences position peaked at $197K in Q3 2018.
  • 1,084 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2020.

Based on Shine Investment Advisory Services's 13F filing for Q3 2020, filed 3 Nov 2020.